On January 19, 2024, the Chilean Public Health Institute (ISP) issued exempt resolution No. 459 approving guidelines and requirements for the labeling of high-risk medications. In the document, the authority instructs holders of sanitary registration for parenteral solutions of large volume, small volume, and injectables used in anesthesia, intensive therapy, and individual hospital emergencies as outlined in the document, to incorporate color identification on the labels of these products to allow differentiation. This aims to prevent medication errors and, consequently, adverse effects on patients who receive pharmaceutical products.
The ISP has granted a period of 2 years from the date of publication of the resolution for the implementation of these guidelines, without requiring holders to request a labeling modification in the sanitary registration.
You can find the complete document at the following link.
Image designed by Freepik.